Cutler Group LP Cassava Sciences Inc Put Options Transaction History

Cutler Group LP

15 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 Apr 19, 2024	BUY	$18.44 - $26.41 $62,696 - $89,794	3,400 Added 54.84%	9,600 $84,000
Q4 2023 Jan 18, 2024	BUY	$12.64 - $30.11 $72,048 - $171,627	5,700 Added 1140.0%	6,200 $27,000
Q2 2023 Jul 18, 2023	SELL	$21.59 - $27.88 $25,908 - $33,456	-1,200 Reduced 70.59%	500 $7,000
Q1 2023 May 01, 2023	SELL	$23.46 - $36.44 $272,136 - $422,704	-11,600 Reduced 87.22%	1,700 $8,000
Q4 2022 Feb 07, 2023	SELL	$27.82 - $44.16 $578,656 - $918,527	-20,800 Reduced 61.0%	13,300 $107,000
Q3 2022 Oct 25, 2022	SELL	$16.33 - $51.06 $146,969 - $459,540	-9,000 Reduced 20.88%	34,100 $156,000
Q2 2022 Aug 04, 2022	BUY	$17.22 - $38.47 $334,068 - $746,318	19,400 Added 81.86%	43,100 $444,000
Q1 2022 Apr 14, 2022	SELL	$32.6 - $53.05 $427,060 - $694,955	-13,100 Reduced 35.6%	23,700 $104,000
Q4 2021 Jan 18, 2022	SELL	$36.77 - $90.91 $1.38 Million - $3.41 Million	-37,500 Reduced 50.47%	36,800 $132,000
Q3 2021 Oct 26, 2021	BUY	$41.79 - $135.3 $1.04 Million - $3.36 Million	24,800 Added 50.1%	74,300 $313,000
Q2 2021 Jul 19, 2021	BUY	$32.15 - $89.72 $787,675 - $2.2 Million	24,500 Added 98.0%	49,500 $162,000
Q1 2021 Apr 26, 2021	BUY	$7.09 - $87.95 $175,832 - $2.18 Million	24,800 Added 12400.0%	25,000 $151,000
Q4 2020 Jan 21, 2021	SELL	$6.79 - $12.25 $9,506 - $17,150	-1,400 Reduced 87.5%	200 $0
Q3 2020 Oct 27, 2020	BUY	$2.86 - $11.51 $4,290 - $17,265	1,500 Added 1500.0%	1,600 $1,000
Q2 2020 Jul 22, 2020	BUY	$2.04 - $9.64 $204 - $964	100 New	100 $0

207

14M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $154M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.